KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD (Hon.) to its Scientific Advisory Board.
Led by Robert Hauser, MD, former president of the Heart Rhythm Society, the company’s Scientific Advisory Board gathers and applies expertise from top cardiology opinion leaders toward the advancement of cardiac arrhythmia research and patient care. Its members provide the company and industry with medical and scientific expertise in areas related to its current and future products and services. The group is also responsible for recommending scientific studies that will enhance products in terms of quality, market adoption and cost effectiveness.
Camm is Professor of Clinical Cardiology at St. George's, University of London, and Professor of Cardiology at London’s Imperial College. He is a Fellow of the Royal College of Physicians, and an experienced researcher and clinician focused on addressing specific issues associated with atrial fibrillation, other cardiac arrhythmias and sudden cardiac death. Camm has led a top group of specialists, the European Network for Translational Research in Atrial Fibrillation (EUTRAF). He is currently President of the European Heart Rhythm Association and the Arrhythmia Alliance, among many more distinguished roles.
An international authority on AFib, Dr. Waldo is a recipient of numerous top honorary awards in cardiology and a pioneer in the discovery and development of treatments for rapid heart and other cardiac arrhythmias. Dr. Waldo is The Walter H. Pritchard Professor of Cardiology, Professor of Medicine, and Professor of Biomedical Engineering at Case Western Reserve University School of Medicine, Cleveland, Ohio. He is also Associate Chief of Cardiovascular Medicine for Academic Affairs at University Hospitals Cleveland Medical Center. He has published scientific articles in more than 450 publications; is a Fellow of the American College of Cardiology and served as President of the Ohio Chapter; former President of the North American Society of Pacing and Electrophysiology (NASPE), now called the Heart Rhythm Society (HRS); a Fellow and founding member of HRS; a Fellow of the American College of Physicians, American Heart Association and the American College of Chest Physicians; served as President of the Cardiac Electrophysiology Society; held committee memberships with the National Institutes of Health, among many other distinguished roles.
Cardiac Insight stated the two additions are complementary to its global outreach efforts and represent the growing credibility building around the company’s products and direction.
“We are honored to welcome Professor Camm and Dr. Waldo to Cardiac Insight’s community of cardiologists and scientists driving the innovation and research behind our revolutionary medical devices and software,” said Chief Executive Officer, Brad Harlow. “Both represent the growing appeal of our approach and expanding global outreach. The revolutionary applications of their expertise and notoriety in our company’s focal areas will provide monumental contributions to the evolution of our product offerings and valuable data to the cardiology discipline.”
Cardiac Insight’s two main products are ECG devices and software designed to target two distinct and significant healthcare market needs: detection of adult cardiac arrhythmias, including atrial fibrillation or AFib, and identification of the risk of Sudden Cardiac Arrest in young athletes.
About Cardiac Insight, Inc.:
Cardiac Insight, Inc. (www.cardiacinsightinc.com) is a leading U.S. developer of advanced body-worn digital health care information devices that address unique diagnostic challenges for patients with cardiology, respiratory and other complex disease states. The company’s two flagship products are Cardea SOLO™ (www.cardeasolo.com) and Cardea 20/20 ECG™. The company is based in Kirkland, Washington.